Որոնման արդյունքները - Ignacio Matos
- Ցուցադրվում են 1 - 16 արդյունքները 16
-
1
-
2
-
3
-
4
Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1–4 inhibitor in patients with advanced solid tumors Rastislav Bahleda, Funda Meric‐Bernstam, Lipika Goyal, Ben Tran, Yi He, Ikuo Yamamiya, Karim A. Benhadji, Ignacio Matos, Hendrik‐Tobias Arkenau
Հրապարակվել է 2020Artigo -
5
ODONTOLOGIA FORENSE: ANÁLISE DE MORDEDURAS EM CASOS DE ABUSOS E MAUS TRATOS INFANTIS Ignacio Matos, Heno Ferreira Lopes, Maria Reis, Mario Magno Pacífico Chaves Júnior, Thalita Medeiros Fernandes de Macêdo, Giselle Maria Ferreira Lima Verde
Հրապարակվել է 2024Artigo -
6
Atuação do cirurgião dentista na prevenção de infecções respiratórias em pacientes nas unidades de terapia de terapia intensiva Ignacio Matos, Thalita Medeiros Fernandes de Macêdo, Thiago Moreira, B. S. Lima, Camila Fagundes, Fábio Catão, Guilherme Oliveira de. Sousa, Gisele Cássia de Sousa, Heno Ferreira Lopes, Maria Reis
Հրապարակվել է 2024Artigo -
7
Early evolutionary divergence between papillary and anaplastic thyroid cancers J. Capdevila, Regina Mayor, Francesco M. Mancuso, Carmela Iglesias, Ginevra Caratù, Ignacio Matos, Carles Zafón, Jorge Hernando, A. Petit, Paolo Nucíforo, José Cameselle‐Teijeiro, Clara V. Álvarez, Juan A. Recio, Josep Tabernero, Xavier Matías‐Guiu, Ana Vivancos, Joan Seoane
Հրապարակվել է 2018Artigo -
8
The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407) Enrique Grande, Àlex Teulé, Teresa Alonso‐Gordoa, Paula Jiménez‐Fonseca, Marta Benavent, Jaume Capdevila, Ana Custodio, Ruth Vera, Javier Munárriz, Adelaida La Casta, Juan J. Díez, Pablo Gajate, Javier Molina‐Cerrillo, Ignacio Matos, Eva Cristóbal, J.C. Ruffinelli, José Palacios, Rocio García‐Carbonero
Հրապարակվել է 2020Artigo -
9
Analysis of mutant allele fractions in driver genes in colorectal cancer – biological and clinical insights Rodrigo Dienstmann, Elena Élez, Guillem Argilés, Ignacio Matos, Enrique Sanz‐García, Carolina Ortiz, Teresa Macarulla, Jaume Capdevila, María Alsina, Tamara Saurí, Helena Verdaguer, Marta Vilaró, Fiorella Ruíz‐Pace, Cristina Viaplana, Ariadna García, Stefania Landolfi, Héctor G. Pálmer, Paolo Nucíforo, Jordi Rodón, Ana Vivancos, Josep Tabernero
Հրապարակվել է 2017Artigo -
10
1913O Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET+ MTC) Mimi I. Hu, Vivek Subbiah, Lori J. Wirth, M Schuler, Aaron S. Mansfield, Marcia S. Brose, Giuseppe Curigliano, Sophie Leboulleux, Viola W. Zhu, Bhumsuk Keam, Ignacio Matos, C-C. Lin, D.R. Adkins, Christina S. Baik, G. Lopes, Yann Godbert, Debashis Sarker, H. Zhang, Christopher D. Turner, Matthew Taylor
Հրապարակվել է 2020Artigo -
11
Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics Maria Lozano-Rabella, Andrea García-Garijo, Jara Palomero, Anna Yuste-Estevanez, Florian Erhard, Roc Farriol-Duran, Juan Martín-Liberal, Maria Ochoa de Olza, Ignacio Matos, Jared J. Gartner, Michael Ghosh, Francesc Canals, August Vidal, Josep M. Piulats, Xavier Matías‐Guiu, Irene Braña, Eva Muñoz‐Couselo, Elena Garralda, Andreas Schlösser, Alena Gros
Հրապարակվել է 2023Carta -
12
Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies Hyun Cheol Chung, Sarina A. Piha‐Paul, José A. López-Martín, Jan H.M. Schellens, Steven Kao, Wilson H. Miller, Jean‐Pierre Delord, Bo Gao, David Planchard, Maya Gottfried, Alona Zer, Shadia I. Jalal, Nicolas Penel, Janice M. Mehnert, Ignacio Matos, Jaafar Bennouna, Dong‐Wan Kim, Lei Xu, Suba Krishnan, Kevin Norwood, Patrick A. Ott
Հրապարակվել է 2019Artigo -
13
Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria Ignacio Matos, Juan Martín-Liberal, Alonso García-Ruiz, Cinta Hierro, María Ochoa de Olza, Cristina Viaplana, Analía Azaro, María Vieito, Irene Braña, Gemma Mur, Javier Ros, José M. Mateos, Guillermo Villacampa, Roger Berché, Mafalda Oliveira, María Alsina, Elena Élez, Ana Oaknin, Eva Muñoz‐Couselo, Joan Carles, Enriqueta Felip, Jordi Rodón, Josep Tabernero, Rodrigo Dienstmann, Raquel Pérez-López, Elena Garralda
Հրապարակվել է 2019Artigo -
14
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509) Jaume Capdevila, Nicola Fazio, Carlos López, Àlex Teulé, Juan W. Valle, Salvatore Tafuto, Ana Custodio, Nicholas S. Reed, Markus Raderer, Enrique Grande, Rocio García‐Carbonero, Paula Jiménez‐Fonseca, Jorge Hernando, Alberto Bongiovanni, Francesca Spada, Vicente Alonso, Lorenzo Antonuzzo, Andrea Spallanzani, Alfredo Berruti, Adelaida La Casta, Isabel Sevilla, Patrizia Kump, Dario Giuffrida, Xavier Merino, Lorena Marianne Villalobos Trejo, Pablo Gajate, Ignacio Matos, Ángela Lamarca, Toni Ibrahim
Հրապարակվել է 2021Artigo -
15
A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia Fonseca, Paula Jiménez, Carmona-Bayonas, Alberto, García, Ignacio Matos, Marcos, Rosana, Castañón, Eduardo, Antonio, Maite, Font, Carme, Biosca, Mercè, Blasco, Ana, Lozano, Rebeca, Ramchandani, Avinash, Beato, Carmen, de Castro, Eva Martínez, Espinosa, Javier, Martínez-García, Jerónimo, Ghanem, Ismael, Cubero, Jorge Hernando, Manrique, Isabel Aragón, Navalón, Francisco García, Sevillano, Elena, Manzano, Aránzazu, Virizuela, Juan, Garrido, Marcelo, Mondéjar, Rebeca, Arcusa, María Ángeles, Bonilla, Yaiza, Pérez, Quionia, Gallardo, Elena, del Carmen Soriano, Maria, Cardona, Mercè, Lasheras, Fernando Sánchez, Cruz, Juan Jesús, Ayala, Francisco
Հրապարակվել է 2016Տեքստ -
16
PL02.08 Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers Alexander Drilon, Geoffrey R. Oxnard, Lori J. Wirth, Benjamin Besse, Oliver Gautschi, Sichuang Tan, Herbert H. Loong, Todd M. Bauer, Yoon Jun Kim, Atsushi Horiike, K. Park, Manisha H. Shah, Caroline E. McCoach, Lyudmila Bazhenova, Takeshi Seto, Marcia S. Brose, Nathan A. Pennell, Jared Weiss, Ignacio Matos, Nir Peled, Byoung Chul Cho, Y. Ohe, Karen L. Reckamp, Valentina Boni, Miyako Satouchi, Gerald S. Falchook, Wallace Akerley, Haruko Daga, Tomohiro Sakamoto, Jyoti D. Patel, Nehal J. Lakhani, Fabrice Barlési, Mark E. Burkard, Viola W. Zhu, Víctor Moreno, Jacques Médioni, Marc Matrana, Christian Rolfo, D.H. Lee, Hovav Nechushtan, Melissa L. Johnson, Vamsidhar Velcheti, Matomo Nishio, Ryo Toyozawa, Kadoaki Ohashi, Lixin Song, Junyi Han, Alexander I. Spira, Filippo de Braud, Kristoffer Staal Rohrberg, Shinji Takeuchi, Jun Sakakibara, S. Waqar, Hirotsugu Kenmotsu, F. Perry Wilson, Bijay Nair, Elizabeth Olek, Jennifer Kherani, Kevin Ebata, Edward Y. Zhu, Mai Nguyen, Luxi Yang, Xin Huang, Scott Cruickshank, S. Michael Rothenberg, Benjamin Solomon, Ken Goto, Vivek Subbiah
Հրապարակվել է 2019Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Medicine
Internal medicine
Oncology
Cancer
Biology
Cancer research
Clinical trial
Gastroenterology
Genetics
Immunotherapy
Phases of clinical research
Response Evaluation Criteria in Solid Tumors
Astrobiology
Chemotherapy
Colorectal cancer
Gene
Immune system
Immunology
Intensive care medicine
Neuroendocrine tumors
Pathology
Pharmacology
Physics
Progressive disease
Refractory (planetary science)
Surgery
Thyroid cancer
A549 cell
Adverse effect
Allele